Author: Mike Vodicka

3 Early Leaders Ready to Cash in if New Jersey Goes Legal on November 3

Posted on by Mike Vodicka

November 3 is a big day for the U.S. cannabis industry. Five U.S. states will vote on measures to legalize medical or recreational cannabis.

Leading cannabis market research firm New Frontier Data’s new research report projects that the vote will have a big impact on U.S. cannabis sales.

“The 2020 election could be one of the most consequential and historical events to change the landscape of the legal U.S. cannabis industry,” said New Frontier Data Founder & CEO Giadha A. DeCarcer. “With $9 billion in new revenue from 2022-2025, should all five states ballot measures pass, New Frontier Data estimates that revenues from all legal U.S. markets will reach $35.1B in 2025.”

From the group of five U.S. states getting ready to vote on legalization, none is more important than New Jersey for two reasons. Continue reading “3 Early Leaders Ready to Cash in if New Jersey Goes Legal on November 3” →

2 Reasons to Avoid Aurora Cannabis

Posted on by Mike Vodicka

Back in 2019, Aurora Cannabis was the rock star of the cannabis industry. At its peak, Aurora nabbed a market cap of $10 billion.

The company had delivered enormous gains to early investors. It also and ranked as the #1 held stock on the popular stock trading app, Robinhood.

The enthusiasm was driven by Aurora’s impressive portfolio of cannabis businesses and assets.

That portfolio included 15 global cannabis cultivation centers capable of producing more than 700,000 kilograms of cannabis per year. Aurora had also secured exclusive cannabis permits in potentially lucrative international markets including Germany and Australia. Aurora invested hundreds of millions to build an unparalleled global cannabis production and distribution network.

However, customers never showed up. Continue reading “2 Reasons to Avoid Aurora Cannabis” →

Invest in Magic Mushrooms with a $100 Million IPO

Posted on by Mike Vodicka

Cannabis investors looking for the next big thing need to take a look at psychedelic stocks. Not only is the industry growing rapidly, but a promising young biotech, led by a Facebook billionaire, just filed to go public.

Hot on the heels of cannabis, psychedelic mushrooms are quickly gaining credibility for their medicinal value.

Researchers and users are discovering that psilocybin, the psychedelic compound found in “magic mushrooms,” can be a highly effective treatment for depression.

This information is giving birth to a new industry, psychedelic pharmaceutical drugs. Analysts expect this industry to grow sharply in the coming years. Continue reading “Invest in Magic Mushrooms with a $100 Million IPO” →

Pennsylvania’s COVID Recovery Plan Includes Cannabis

Posted on by Mike Vodicka

Like many other states, the Pennsylvania economy has been wounded by COVD-19. However, the governor has a solution to repair some of the damage – legalize cannabis.

On Tuesday, Pennsylvania governor Tom Wolf (D) announced that legalizing recreational cannabis is a high priority on his fall legislative agenda. Continue reading “Pennsylvania’s COVID Recovery Plan Includes Cannabis” →

2020 U.S. Election is Massive Catalyst for Cannabis Stocks

Posted on by Mike Vodicka
  • The U.S. presidential election should be a huge catalyst for the cannabis industry, with up to 7 states voting on legalization.
  • Biden-Sander’s Unity Plan would basically legalize cannabis in the U.S.
  • Some of the best stocks in the industry are trading more than 50% below the 52-week high.
  • Not all cannabis stocks will do well – investors need to know which companies are set to prosper and which ones will fail.

I see two powerful catalysts directly on the horizon for cannabis stocks and an elite group of cannabis stocks are already starting to take off. For anyone who does not already own these stocks, there is still time to get in. Continue reading “2020 U.S. Election is Massive Catalyst for Cannabis Stocks” →

Jeff Sessions Cole Memo Update – Cannabis Stock Trades

Posted on by Mike Vodicka
Greetings Friends,
Cannabis stocks took a hit today after US Attorney General Jeff Sessions rescinded the Cole Memo – legislation that basically makes it illegal for the Feds to go after state cannabis programs.
In the short run cannabis stocks are down. But in the long run I don’t think this will have any impact on the cannabis industry or the potential of cannabis stocks.
Here’s a video with some more thoughts.

Canada to Legalize Cannabis by July 2018

Posted on by Mike Vodicka

The cannabis industry scored a huge victory this week. And if my analysis is correct, cannabis stocks are setting up for a big rally in the next few weeks and even bigger rally in the long run. Let me explain.

On Sunday night, news leaked that on April 10 Canada will announce plans to legalize recreational cannabis by July of 2018. Here’s some coverage from CBCNews if you’d like to take a closer look. Continue reading “Canada to Legalize Cannabis by July 2018” →

Cannabis Stocks Are Officially On Sale

Posted on by Mike Vodicka

If you are the kind of person who loves getting a great deal, the cannabis sector is calling your name.

Cannabis stocks are officially on sale.

This blast of weakness has been driven by two things.

There are still lingering concerns over US drug policy after some questionable comments on cannabis enforcement from White House Press Secretary, Sean Spicer.

I think these concerns are overblown – read my full trump analysis – but none the less, it has definitely been a lingering concern and weighed on cannabis stocks. Continue reading “Cannabis Stocks Are Officially On Sale” →

First Ever Australian Cannabis Stock Set to Lead Industry

Posted on by Mike Vodicka

Cannabis legalization isn’t just happening in the U.S and Canada. It’s happening all across the world. It seems like every month or so a new country joins the party.

For example, In early 2016 Colombia’s Congress voted to legalize cannabis for medical and scientific purposes.

In the Middle East, Israel is decriminalizing cannabis for recreational purposes.

In late January, Germany passed a bill legalizing the production, sale, and use of medical cannabis. Continue reading “First Ever Australian Cannabis Stock Set to Lead Industry” →